UBS Group AG - REGULUS THERAPEUTICS INC ownership

REGULUS THERAPEUTICS INC's ticker is and the CUSIP is 75915K309. A total of 29 filers reported holding REGULUS THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of REGULUS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$558
-89.5%
408
-88.7%
0.00%
Q2 2023$5,310
+260.2%
3,612
+107.8%
0.00%
Q1 2023$1,474
-81.0%
1,738
-69.3%
0.00%
Q4 2022$7,757
-54.4%
5,662
-44.4%
0.00%
Q3 2022$17,0000.0%10,176
+23.3%
0.00%
Q2 2022$17,0008,2520.00%
Other shareholders
REGULUS THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 555,555$1,150,0000.31%
Ikarian Capital, LLC 105,341$217,0000.04%
Sarissa Capital Management LP 185,183$383,0000.04%
FEDERATED HERMES, INC. 2,904,826$6,013,0000.02%
Virtu Financial LLC 10,205$21,0000.00%
VICTORY CAPITAL MANAGEMENT INC 221,506$459,0000.00%
BOOTHBAY FUND MANAGEMENT, LLC 11,583$24,0000.00%
VANGUARD GROUP INC 372,732$772,0000.00%
UBS Group AG 8,252$17,0000.00%
Community Bank, N.A. 690$1,0000.00%
View complete list of REGULUS THERAPEUTICS INC shareholders